Entry |
|
Name |
Phenylpropanolamine polistirex (USAN) |
Class |
Cardiovascular agent
DG01456 Adrenergic receptor agonist
Metabolizing enzyme inhibitor
DG01634 CYP1A2 inhibitor
|
Remark |
|
Efficacy |
Vasoconstrictor, Adrenergic receptor agonist |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
hsa04270 | Vascular smooth muscle contraction |
|
Interaction |
CYP inhibition: CYP1A2 [HSA: 1544]
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R01 NASAL PREPARATIONS
R01B NASAL DECONGESTANTS FOR SYSTEMIC USE
R01BA Sympathomimetics
R01BA01 Phenylpropanolamine
D05466 Phenylpropanolamine polistirex (USAN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01041 Phenylpropanolamine
D05466 Phenylpropanolamine polistirex
Metabolizing enzyme inhibitor
DG01634 CYP1A2 inhibitor
DG01041 Phenylpropanolamine
D05466 Phenylpropanolamine polistirex
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Adrenaline
ADRA1
D05466 Phenylpropanolamine polistirex (USAN)
ADRA2
D05466 Phenylpropanolamine polistirex (USAN)
ADRB
D05466 Phenylpropanolamine polistirex (USAN)
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D05466
Drug groups [BR:br08330]
Cardiovascular agent
DG01456 Adrenergic receptor agonist
DG01041 Phenylpropanolamine
Metabolizing enzyme inhibitor
DG01634 CYP1A2 inhibitor
DG01041 Phenylpropanolamine
|
Other DBs |
|
LinkDB |
|